San Francisco Health Officials Report COVID and Monkeypox Case Updates
July 05, 2022 | San Francisco City, San Francisco County, California
This article was created by AI summarizing key points discussed. AI makes mistakes, so for full details and context, please refer to the video of the full meeting. Please report any errors so we can fix them. Report an error »
The San Francisco City Council convened on July 4, 2025, to discuss pressing public health issues, primarily focusing on COVID-19 and monkeypox updates. Health Officer Susan Phillip provided a detailed overview of the current situation regarding COVID-19 cases, deaths, and vaccination rates.
The meeting began with a report on COVID-19 case rates, which peaked at 58.2 but are now showing a gentle decline. However, the emergence of variants BA 4 and 5 raises concerns about a potential plateau or slight increase in cases. Phillip noted that local, state, and national health authorities are closely monitoring these trends.
In terms of mortality, there has been a small increase in COVID-related deaths, although current rates are approximately half of what they were during the peak in January. Vaccination continues to play a crucial role in protecting residents, with unvaccinated individuals experiencing significantly higher case rates compared to those who have completed their initial vaccine series.
Hospitalization rates have seen fluctuations, with some increases noted. Phillip emphasized the challenge of distinguishing between patients admitted for COVID-19 versus those who tested positive incidentally during treatment for other conditions. Vaccination rates remain high, particularly among older residents, with 90% of individuals aged 75 and above having received their vaccinations.
The discussion then shifted to monkeypox, where Phillip reported 40 confirmed and probable cases in San Francisco, part of a larger national trend. The city has updated its vaccination eligibility criteria to include individuals who have had close contact with confirmed cases. However, the JYNNEOS vaccine is currently in short supply, with only 580 doses received to date.
Efforts to disseminate information about monkeypox are ongoing, with outreach to various community organizations and venues where potential exposure could occur. The health department is working with local health systems to improve vaccine access as more doses become available.
In conclusion, the meeting highlighted the city's proactive approach to managing both COVID-19 and monkeypox, emphasizing the importance of vaccination and community outreach in mitigating the spread of these diseases. The health department plans to continue monitoring the situation closely and will provide updates as new data emerges.
The meeting began with a report on COVID-19 case rates, which peaked at 58.2 but are now showing a gentle decline. However, the emergence of variants BA 4 and 5 raises concerns about a potential plateau or slight increase in cases. Phillip noted that local, state, and national health authorities are closely monitoring these trends.
In terms of mortality, there has been a small increase in COVID-related deaths, although current rates are approximately half of what they were during the peak in January. Vaccination continues to play a crucial role in protecting residents, with unvaccinated individuals experiencing significantly higher case rates compared to those who have completed their initial vaccine series.
Hospitalization rates have seen fluctuations, with some increases noted. Phillip emphasized the challenge of distinguishing between patients admitted for COVID-19 versus those who tested positive incidentally during treatment for other conditions. Vaccination rates remain high, particularly among older residents, with 90% of individuals aged 75 and above having received their vaccinations.
The discussion then shifted to monkeypox, where Phillip reported 40 confirmed and probable cases in San Francisco, part of a larger national trend. The city has updated its vaccination eligibility criteria to include individuals who have had close contact with confirmed cases. However, the JYNNEOS vaccine is currently in short supply, with only 580 doses received to date.
Efforts to disseminate information about monkeypox are ongoing, with outreach to various community organizations and venues where potential exposure could occur. The health department is working with local health systems to improve vaccine access as more doses become available.
In conclusion, the meeting highlighted the city's proactive approach to managing both COVID-19 and monkeypox, emphasizing the importance of vaccination and community outreach in mitigating the spread of these diseases. The health department plans to continue monitoring the situation closely and will provide updates as new data emerges.
View the Full Meeting & All Its Details
This article offers just a summary. Unlock complete video, transcripts, and insights as a Founder Member.
✓
Watch full, unedited meeting videos
✓
Search every word spoken in unlimited transcripts
✓
AI summaries & real-time alerts (all government levels)
✓
Permanent access to expanding government content
30-day money-back guarantee
